Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ilya Andreevich Fedotov has a total of 234 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Profiles of Cognitive Appraisal of Non-Suicidal Self-Injury Scars and Their Clinical Correlates in Adults with a History of Self-Injury: A Cross-Sectional Study

    by Alexandrina A. Grigoreva, Ilya A. Fedotov, Maksim P. Marachev, Anastasia K. Kondratovich

    Scars are the most durable consequence of non-suicidal self-injury (NSSI), but how patients appraise them, and how appraisal dimensions combine within individuals, remains unclear. In this cross-sectional study, 234 adults with a history of NSSI and at least one scar, recruited consecutively in Ryazan and Moscow, Russia, completed the Russian NSSI Scar Cognition Scale (Hopelessness, Shame, Inner Strength) and measures of suicidal ideation, social anxiety, rumination, body-image dysphoria and NSSI functions. Profiles were derived by cluster analysis and tested for stability. Three stable profiles emerged: low-salience (55.1%), negative-dominant (28.2%) and strength-dominant (16.7%). The negative-dominant profile showed the highest suicidal ideation, social anxiety, rumination, body-image dysphoria and self-punishment; the strength-dominant profile showed suicidal ideation and social anxiety similar to the low-salience profile, intermediate rumination and body-image dysphoria, and the strongest endorsement of NSSI functions. These differences persisted after covariate adjustment. Scar appraisal explained a further 7.9% of variance in suicidal ideation beyond demographics, self-injury status and general distress; scar visibility explained none. In behavioural remission, the negative-dominant profile reported higher suicidal ideation than the other profiles. Scar appraisal distinguishes subgroups with different clinical correlates. Longitudinal studies are needed to establish whether these profiles predict outcomes or can guide treatment.

  • Initial results of search for neuropsychological markers of the schizophrenia endophenotype in patients with synthetic cathinone-induced psychotic disorders: a cross-sectional study

    by Ilya A. Fedotov, Федотов Илья Андреевич, Dmitri I. Shustov, Шустов Дмитрий Иванович, Vladimir V. Novikov, Новиков Владимир Владимирович, Boris Yu. Volodin, Володин Борис Юрьевич

    BACKGROUND: The rising incidence of psychotic disorders (PDs) induced by synthetic cathinones (SCs) underscores the relevance of search for markers for differentiating this pathology from schizophrenia spectrum psychoses. AIM: To investigate neuropsychological markers of the schizophrenia endophenotype in patients with SC-induced psychotic disorders (SCIPD) and evaluate a possibility of their use in differential diagnosis. METHODS: This observational, cross-sectional, randomized study was conducted from September 2023 to December 2025. Participants were allocated into four groups: Group 1 (healthy controls, n=32); Group 2 (patients with psychostimulant dependence syndrome (PSDS), n=31)), Group 3 (patients with SCIPD, n=30), Group 4 (patients with schizophrenia, n=30). Neuropsychological markers of the schizophrenia endophenotype, selected based on data of meta-analyses, were evaluated using the following instruments: the Continuous Performance Test–Identical Pairs (CPT-IP; DPrime, and False Alarm Catch Rate parameters), the Trail Making Test (parameter Trail B Time and Trail B–Trail A Time difference score), the Stroop test (processing speed and accuracy/inhibition indices), and the Edinburgh Handedness Inventory–Laterality Quotient (EHI-LQ; dominant lateralization index). All tests were performed in the Inquisit computerized environment (Millisecond Inc., USA). RESULTS: The control group performed significantly better than all clinical groups on the DPrime (CPT-IP) and Trail B Time parameters. Group 3 did not differ from Group 4 in the main neurocognitive parameters, with the exception of a higher False Alarm Catch Rate (CPT-IP) and a more pronounced tendency to left-handedness (EHI-LQ). Between-group comparison across the full marker profile revealed significant differences between controls and all clinical groups, as well as between Groups 2 and 4 (p 0.05). Patients in Group 3 occupied an intermediate position between Groups 2 and 4, not differing significantly from them. CONCLUSION: TThe selected neuropsychological markers of schizophrenia endophenotype, primarily reflecting functioning of the dorsolateral prefrontal cortex, do not differentiate SCIPD from schizophrenia. The deficits of sustained attention and cognitive flexibility identified in patients with SCIPD, indistinguishable from those in schizophrenia, suggest hypofrontality and may point to premorbid vulnerability or dopamine sensitization as a mechanism of transformation into schizophrenia. The increased prevalence of left-handedness in the SCIPD group supports the hypothesis of the presence of a pre-existing schizophrenia endophenotype prior to the onset of substance use.

  • Open Access

    Substance-induced psychotic disorders: hospitalization trends in the Russian Federation, 2000–2024

    by Ilya A. Fedotov, Федотов Илья Андреевич, Valentina V. Kirzhanova, Киржанова Валентина Васильевна, Konstantine V. Vyshinsky, Вышинский Константин Витальевич, Pavel A. Ponizovskiy, Понизовский Павел Александрович, Dmitri I. Shustov, Шустов Дмитрий Иванович

    BACKGROUND: The prevalence of substance-induced psychotic disorders (SIPDs), particularly those induced by synthetic psychostimulants and high-potency cannabinoids, represents a global public health concern. АIM: To analyze the trends and factors associated with hospitalizations for SIPDs in the Russian Federation between 2000 and 2024. METHODS: A retrospective epidemiological study was conducted using annual aggregate population-level data from federal statistical surveillance. Variables included hospitalization rates for psychotic disorders induced by illegal and legal psychoactive substances, dependence syndromes, and the quantities of illicit drugs seized. Data were analyzed using nonparametric statistical methods. RESULTS: Two clusters were identified in the trends of the general drug use situation: 2000–2013 and 2014–2024. In the second period, the rate of hospitalizations for patients with SIPD was six times higher, and the structure of substance use-related morbidity underwent a transformation: a 2.9-fold decrease in the annual hospitalization rates for opioid dependence syndrome, accompanied by a 16.4-fold increase in hospitalizations for psychostimulant dependence syndrome, a 3.1-fold increase for cannabinoid dependence, and a 7.4-fold increase for dependence on other psychoactive substances and their combinations. According to the regression analysis, half of the variability in the hospitalization indicator for SIPD is explained by the hospitalization indicator for dependence on psychostimulants or other psychoactive substances and their combinations, while the other half is explained by the hospitalization rate for dependence on cannabinoids. CONCLUSION: The sixfold increase in the hospitalization rate for SIPDs observed in Russia since 2013 may be linked to changes in general drug use patterns — rise in the hospitalization rates for dependence syndromes on synthetic stimulants, cannabinoids and other psychoactive substances and their combinations, accompanied by a decline in hospitalizations for opioid dependence.

  • Open Access

    Negative Symptoms Associated with Psychotic Disorders Induced by Narcotic Substances

    by I. A. Fedotov, D. I. Shustov, V. G. Fateeva, N. N. Petrova

    Background : the characteristics of negative symptoms of drug-induced psychotic disorders (PD) caused by narcotic substances (NS) remain incompletely understood, which impedes the differential diagnosis with schizophrenia . The aim was to compare the presentation and severity of negative symptoms after psychotic disorders induced by the narcotic substances and schizophrenic psychosis in determining their significance for differential diagnosis. Patients and Methods : an observational cross-sectional study was conducted involving 141 patients, who were divided into 4 groups: 1) 21 patients with PD caused by natural cannabinoids; 2) 56 patients with PD induced by the synthetic cathinones; 3) 29 patients with PD induced by the several NS; 4) 35 patients with schizophrenia. Negative symptoms were assessed using the CAINS clinical interview, adapted for the Russian-speaking population. Statistical analysis included nonparametric methods of comparing multiple groups and subsequent post hoc analysis. Results : patients with schizophrenia had statistically significantly more pronounced negative symptoms on the emotional expressiveness subscale compared to all groups of narcotic-induced psychoses (p < 0.001). According to the CAINS total score, patients with schizophrenia differed signficantly from the synthetic cathinones-induced PD and several narcotic-induced PD groups (p < 0.001), but not from the natural cannabinoids-induced PD group (p = 0.47). Patients with natural cannabinoids-induced PD demonstrated the most pronounced negative symptoms among all groups of narcotics-induced psychoses, which were similar to schizophrenia in all areas, except emotional expressiveness. The synthetic cathinones-indused PD and several narcotic-induced PD groups were characterized by significantly less pronounced anticipatory negative symptoms and better motivation in the social, professional, and recreational spheres than patients with schizophrenia. Conclusion : significant differences in the profile of negative symptoms between psychotic disorders induced by different NS were identified. PD induced by natural cannabinoids were the closest ones to schizophrenia in the severity of negative symptoms, which is clinically significant for differential diagnosis and planning rehabilitation measures.

  • Open Access

    Predictors of delirium not induced by alcohol or other psychoactive substances in older patients: a scoping review

    by Ilya A. Fedotov, Федотов Илья Андреевич, Anastasia A. Radostina, Радостина Анастасия Андреевна, Aleksandr O. Burshinov, Буршинов Александр Олегович, Roman A. Zorin, Зорин Роман Александрович

    The evolution of digital psychiatry is opening up new possibilities for predicting acute life-threatening psychiatric disorders, such as delirium (an acute state of mental confusion) not caused by alcohol or psychoactive substances (F05 according to ICD-10). A scoping review was conducted according to PRISMA-ScR recommendations in the eLibrary, CNKI, PubMed, and Google Scholar databases (March 2026). Original studies and reviews describing methods for diagnosing delirium, clinical conditions for enrollment, independent predictors, and statistical power of models were included. Among the 54 included publications, 37 models were based on prospective studies and 17 on retrospective studies; 36 models used logistic regression and 18 used machine learning methods. Three domains of delirium diagnosis have been identified: cognitive, complex thinking operations, and circadian. These domains are evident in all clinical diagnostic approaches used. The most valid clinical predictors include: age over 80 years, severity of somatic condition, reduced daily activity, premorbid cognitive decline/dementia, history of delirium, cardiovascular and cerebrovascular comorbidity, polypharmacy, use of anticholinergic drugs, abnormalities in vital signs, and visual and hearing impairments. Laboratory predictors of delirium are classified into three groups: markers of inflammation (interleukin-6, C-reactive protein, TNF-α, platelet indices), markers of neurodegeneration (neurofilament light chain, S100B protein, neuron-specific enolase), and markers of metabolic disorders (urea-to-creatinine ratio, electrolytes, lactate). Among electroencephalography techniques, spectral analysis of rhythm power, wavelet analysis, bispectral index, and patient status index are promising. Morphometric predictors include white matter hyperintensity, global brain atrophy, and diffusion tensor imaging abnormalities. Combining clinical and paraclinical data increases the statistical power of models (AUC up to 0.85–0.92). Modern models for predicting delirium in elderly patients are gradually switching from regression analysis to machine learning, which improves the accuracy of predictions. The integration of clinical predictors with biomarkers of inflammation and neurodegeneration, as well as quantitative electroencephalography indicators and morphometric data, represents the most promising direction for the development of validated risk assessment algorithms adapted to regional characteristics of clinical practice.

  • The Potential of Synthetic Cathinones to Block the Membrane Dopamine Transporter: A Summary of Our Molecular Docking Results and Data from In vitro and In vivo Experiments in the Literature

    by Ilya A. Fedotov, Dmitry I. Shustov

    Introduction: The behavioral sensitization (BS) model for psychostimulants is the most developed framework for explaining the occurrence of drug-induced psychoses. However, there is limited data on the potential of synthetic cathinones (SCs) to induce BS, which restricts the model’s full application in understanding this phenomenon. Aim: This study aimed to provide theoretical evidence regarding the potential of synthetic cathinones to inhibit the dopamine membrane transporter at levels sufficient to induce behavioral sensitization. Methods: The following SCs were selected as ligands: 4-methylmethcathinone (mephedrone), 3,4- methylenedioxypyrovalerone (MDPV), and alpha-pyrrolidinovalerophenone (alpha-PVP). Amphetamine and cocaine were included for comparison. Molecular docking was performed using Auto- Dock Vina and the Attracting Cavities algorithms. The human dopamine transporter structure was obtained from the Protein Data Bank (PDB ID: 8Y2DS). Additionally, PubMed, CNKI, and eLibrary databases were searched to compare the docking results with experimental data from cell lines and animal studies; 13 publications were included in the analysis. Results: All synthetic cathinones studied showed no significant differences in binding affinity to the orthosteric site of the dopamine membrane transporter, suggesting that they may act similarly to amphetamine and cocaine. These findings were corroborated by experiments in cell lines. For mephedrone and MDPV, the potential to induce behavioral sensitization (BS) was also confirmed in animal studies. Conclusion: Theoretically, mephedrone, MDPV, and alpha-PVP can inhibit the dopamine membrane transporter, leading to increased extracellular dopamine levels and promoting the development of dopamine hypersensitivity and behavioral sensitization.

  • Borderline Personality Disorder and Borderline Character Accentuation: a Comparison of Suicidal Characteristics in Women

    by Farah Trabelsi, Dmitriy S. Petrov, Vladimir V. Novikov, Boris Yu. Volodin, Ilya A. Fedotov

    BACKGROUND: Borderline personality disorder (BPD) currently remains an important topic in psychiatric research due to significant prevalence of self-injurious behavior in individuals with this disorder. However, differences in the suicidal behavior between patients with BPD and those exhibiting only specific borderline personality traits (BPT) — character accentuation are understudied. AIM: To identify and describe differences in suicidal behavior characteristics between patients with BPD and BPT for development of personalized prevention programs. METHODS: This observational cross-sectional study involved 120 female patients with a history of self-injurious behavior undergoing inpatient treatment in Bazhenov Ryazan Regional Clinical Psychiatric Hospital. For assessment, adapted specialized clinical and psychometric scales were used. RESULTS: Patients with BPD demonstrated more pronounced emotional dysregulation (p <0.0001), cognitive impairment (p <0.0001), impulsive behavior (p<0.0001), and dysfunction in interpersonal relationships (p <0.001). In addition, they showed more significant results for negative affects (p <0.0001), detachment (p=0.0001), antagonism (p=0.0009), disinhibition (p <0.0001), psychoticism (p <0.0001), anxiety (p <0.0001), and depression (p <0.0001) among the personality patterns in the ‘Personality Inventory for DSM-5 — Brief Form’ (PID5BF). Patients with BPD had statistically significant differences in the following suicide risk factors: emotionality (p <0.0001), incompetence (p <0.0001), pessimism (p <0.0001), decreased time perspective (p <0.0001), demonstrativeness (p <0.0001), and uniqueness (p <0.0001). In addition, they expressed fear of being forgotten after death (p=0.0112). The BPT group had a statistically significantly higher score in the anti-suicide index (p=0.0076). According to the Mini-SMIL results, the BPT group had significantly higher scores on the ‘Denial of Anxiety and Hypomanic Tendencies’ scale (p=0.0001). Patients with BPD showed significantly higher results on the following scales: ‘Somatic anxiety’ (p=0.0084), ‘Anxiety and depressive tendencies’ (p=0.0009), ‘Repression of factors causing anxiety’ (p=0.0224), ‘Realization of emotional orientation in direct behavior, impulsiveness’ (p=0.0002), ‘Fixation of anxiety and restrictive behavior’ (p=0.0005) and the autism scale (p=0.0006). CONCLUSION: The study results showed that self-harming behavior in female patients with BPD and those with BPT had different characteristics, which is important to take into account in prevention programs.

  • The effect of prospective thinking and self-destructive behavior characteristics on the duration of therapeutic remission in stimulant addiction

    by E. V. Leonov, D. I. Shustov, O. D. Tuchina, D. S. Petrov, I. A. Fedotov

    In order to analyze the factors influencing remission duration in patients with stimulant dependence syndrome, specifically parameters of self-destructive behavior and prospective thinking, a study was conducted involving 112 hospitalized patients – 73 women and 39 men diagnosed with stimulant dependence syndrome (F15.2 according to ICD-10). The median age was 24 years [21.00 ÷ 27.00]. Upon admission, patients completed Beck's Hopelessness Scale, Barratt Impulsiveness Scale, Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES), as well as Interpersonal Needs Questionnaire and Zimbardo Time Perspective Inventory. Additionally, Suicidal Potential Index was calculated. At discharge, patients were retested using Beck's Hopelessness Scale and SOCRATES methodology. After discharge, patients were followed up for six months. Remission factor evaluation was performed using multiple linear regression method. A total of three multiple linear regression models were constructed, assessing multicollinearity and normal distribution of residuals. Study results confirm the multifactorial nature of formation and maintenance of remission in patients with stimulant dependence syndrome. The obtained data emphasize the importance of comprehensive treatment approach including work on negative cognitive schemas, development of prospective thinking, and maintaining motivation for change. Inclusion of therapeutic techniques that enhance planning abilities and stimulate prospective thinking may contribute to increased remission duration in patients with stimulant dependence syndrome.

  • ADAPTATION AND VALIDATION OF THE COMPUTERIZED VERSION OF THE EDINBURGH HANDEDNESS INVENTORY FOR RUSSIAN LANGUAGE:PILOT STUDY

    by Ilya A. Fedotov, Dmitri I. Shustov, Anna G. Faustova, Yulia A. Vinogradova, Anastasia A. Ermakova

    One of the most widely used text questionnaires in the world for determining the lateralization of brain functions is the Edinburgh Handedness Inventory (EHI). It was developed for use with mentally healthy respondents as well as patients with mental disorders. This method has not been adapted or validated in the Russian language. The aim of this study is to translate, adapt, and validate the Edinburgh Handedness Inventory (EHI) method implemented on the Inquisit computer platform. In the first stage, specialists with knowledge of English performed a direct and reverse translation of the method. Two groups of respondents were randomly recruited: people without mental disorders (UPZ, N=30) and patients diagnosed with schizophrenia (PS, N=32). Each respondent completed the EHI methodology (two times) , the Annette test, and a battery of tests to assess frontal lobe dysfunction. Cronbach's alpha coefficient for the UPZ group was 0.98, and for the PS group the coefficient was 0.96. A positive statistically significant correlation was found between responses to even and odd items of the EHI. Test-retest reliability was demonstrated for all parameters of the EHI. The laterality coefficient of the EHI method correlates positively with the Annette test result, which confirms convergent validity, and does not correlate with the results of the battery of tests for frontal lobe dysfunction, which confirms divergent validity. Thus, sufficient evidence has been obtained of the reliability and validity of the Edinburgh Handedness Inventory (EHI) methodology, translated and adapted into Russian and implemented on the Inquisit computer platform.


  • Attitudes toward self-harm scars in patients with borderline personality disorder compared to patients with affective and adjustment disorders

    by F. Trabelsi, A. A. Grigorieva, A. K. Kondratovich, D. S. Petrov, I. A. Fedotov

    Currently, there is not enough research on the mechanisms of cognitive and emotional assessment of scars left after non-suicidal self-injury (NSSI) in maintaining psychological stress and affective difficulties in patients with borderline personality disorder (BPD). The aim of this study is to identify the characteristics of the attitude of patients with BPD toward their scars obtained after NSSI, compared with patients with affective disorders and adjustment disorders (AD). Materials and methods: The study had an observational cross-sectional design (the period from November 2023 to January 2025). Depending on the diagnosis set by a psychiatrist, the patients aged 18 to 60 were divided into 3 groups: 1) the patients with AD (N=130, F43.2 according to ICD-10); 2) the patients with BPD (N=31, F60.3 according to ICD-10); 3) the patients with affective disorders (N=94, codes under section F3 according to ICD-10). In addition to the clinical and demographic questionnaire, the Non-Suicidal Self-Injury Scar Cognition Scale was used. Parametric and non-parametric statistical methods were employed to process the results. Results. The average age of the respondents in all groups did not differ significantly. The respondents in the AD group had a higher level of education and were more likely to be married than the patients with BPD and affective disorders. The patients with BPD were more likely to be divorced. Next, the three groups were compared using various scales of attitude toward scars. When assessing responses on the “hopelessness” scale, the group of the patients with affective disorders showed a significantly higher level compared to the other groups (17.93 points versus 16.5 points in the AD group and 15.0 points in the BPD group, p=0.049). The patients with BPD demonstrated statistically significantly higher scores on the “shame” factor compared to the other groups (12.58 points vs. 11.12 points in the AD group and 11.81 points in the group of the patients with affective disorders, p=0.049). In the third comparison, the group of the patients with AD showed significantly lower scores on the “inner strength” factor when assessing scars than the other groups (8.72 points versus 10.61 points in the group of patients with BPD and 9.95 points in the group of the patients with affective disorders, p=0.008). Conclusion. It has been found that patients suffering from BPD more often experience feelings of shame about their scars after NSSI, but at the same time perceive scars as a symbol of inner strength and overcoming, which indicates more complex psychopathological cognitive patterns of attitude towards the consequences of NSSI with elements of ambivalence. Taking into account the identified characteristics of the attitude towards scars allows for the development of more differentiated and effective strategies for psychotherapeutic intervention, dermatological care, and prevention of self-harm recurrence.